Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) Investor Alert: Investigation of Takeover at $9.50 Per Share
An investigation on behalf of investors, who currently hold shares of Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) shares, was announced concerning whether the takeover of Cornerstone Therapeutics, Inc. by for $9.50 per NASDAQ:CRTX share is unfair to Cornerstone Therapeutics stockholders.
View full press release